Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Jonathan Strober, MD, explains the initial presentation of myasthenia gravis in a pediatric patient population and why initial diagnosis for these patients can be challenging.

Teva’s investigational monoclonal antibody, TEV-53408, has been designed for use in adults with celiac disease, for which a ...

As such, UCB’s recently-debuted, U.S.-based DTC rare-disease campaign Imagine Your Zillions supports its gMG treatment Zilbrysq. The effort is based on flipping the preconceived notions associated ...

Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.

Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia gravis (gMG), one of two drugs that the company hopes will shake up the ...

The International Nuclear and Radiological Event Scale (INES) is a tool for communicating the safety significance of nuclear and radiological events to the public. Member States use INES on a ...

While a bathroom scale may suffice for weighing luggage at home, it’s hardly practical once you’re on the road. If your hotel or accommodation lacks a scale for your return journey ...

MAGI-1 is built upon the Diffusion Transformer, incorporating several key innovations to enhance training efficiency and stability at scale. These advancements include Block-Causal Attention, Parallel ...